IDiyas

For the Inventor, By the Inventor

North Brunswick, NJ, United States of America

John J Venit

USPTO Granted Patents = 17

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • New Brunswick, NJ (US) (2005)
  • North Brunswick, NJ (US) (1998 - 2010)

Company Filing History:

goldMedal17 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents

Years Active: 1998-2010

Loading Chart...
17 patents (USPTO):
1. 7659262 - Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di-amino acid salts, and mono- and di-amino acid ester salts (2010-02-09),
2. 7659261 - Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts (2010-02-09),
3. 7524832 - Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts and mono-and di-amino acid ester salts (2009-04-28),
4. 7388098 - Dynamic resolution of isomers and resolved isomers (2008-06-17),
5. 6968037 - High throughput X-ray diffraction filter sample holder (2005-11-22),
6. 6855702 - Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts (2005-02-15),
7. 6783737 - High pressure chemistry reactor (2004-08-31),
8. 6670344 - Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts (2003-12-30),
9. 6515170 - Enzymatic oxidative deamination process (2003-02-04),
10. 6486331 - Substituted alkylketo compounds and process (2002-11-26),
11. 6468781 - Stereoselective reductive amination of ketones (2002-10-22),
12. 6329542 - Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes (2001-12-11),
13. 6261810 - Enzymatic oxidative deamination process (2001-07-17),
14. 6248882 - Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes (2001-06-19),
15. 6162913 - Preparation of (2000-12-19),

Title: The Innovations of John J Venit

Introduction

John J Venit is a prominent inventor based in North Brunswick, NJ (US), known for his significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, Venit has made remarkable advancements that enhance drug solubility and efficacy.

Latest Patents

His latest patents include the development of Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, as well as mono-and di-amino acid salts and mono-and di-amino acid ester salts. These innovative prodrug salts are designed to increase the solubility of combretastatin A-4, allowing it to regenerate effectively in vivo under normal physiological conditions. The regeneration process results in physiologically tolerable products, showcasing the potential for improved therapeutic applications.

Career Highlights

Venit has built a successful career at Bristol-Myers Squibb Company, where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a lasting impact on the industry.

Collaborations

Throughout his career, Venit has collaborated with notable colleagues, including Keith Ramig and Paul Alan Jass. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John J Venit exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking patents and collaborative efforts. His work continues to influence the development of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…